We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-14.18%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$174M
AUM Growth
-$181M
Cap. Flow
-$142M
Cap. Flow %
-81.5%
Top 10 Hldgs %
28.03%
Holding
1,070
New
55
Increased
89
Reduced
355
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.1%
3 Energy 10.33%
4 Industrials 6.98%
5 Consumer Staples 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROOT icon
476
Root
ROOT
$917M
$1.34K ﹤0.01%
63
-2,611
-98% -$70.7K
GD icon
477
General Dynamics
GD
$105B
$1.33K ﹤0.01%
6
-33
-85% -$7.59K
NCLH icon
478
Norwegian Cruise Line
NCLH
$8.89B
$1.31K ﹤0.01%
118
PM icon
479
Philip Morris
PM
$301B
$1.28K ﹤0.01%
13
-10
-43% -$1.02K
LMND icon
480
Lemonade
LMND
$4.62B
$1.28K ﹤0.01%
70
-4,125
-98% -$86.9K
ORLY icon
481
O'Reilly Automotive
ORLY
$72.4B
$1.26K ﹤0.01%
30
-12,945
-100% -$557K
CGAU
482
Centerra Gold
CGAU
$3.22B
$1.26K ﹤0.01%
+186
New +$1.57K
AB icon
483
AllianceBernstein
AB
$3.47B
$1.25K ﹤0.01%
30
NI icon
484
NiSource
NI
$22.4B
$1.24K ﹤0.01%
42
GEN icon
485
Gen Digital
GEN
$15.6B
$1.23K ﹤0.01%
56
NEO icon
486
NeoGenomics
NEO
$1.81B
$1.23K ﹤0.01%
151
-2,076
-93% -$19.8K
CRSP icon
487
CRISPR Therapeutics
CRSP
$4.58B
$1.22K ﹤0.01%
20
SO icon
488
Southern Company
SO
$110B
$1.21K ﹤0.01%
17
-10,727
-100% -$788K
EBS icon
489
Emergent Biosolutions
EBS
$375M
$1.21K ﹤0.01%
39
-1,206
-97% -$41.2K
CSGP icon
490
CoStar Group
CSGP
$11.3B
$1.21K ﹤0.01%
20
EXK
491
Endeavour Silver
EXK
$2.32B
$1.19K ﹤0.01%
379
-73,230
-99% -$289K
REGN icon
492
Regeneron Pharmaceuticals
REGN
$68.8B
$1.18K ﹤0.01%
2
-241
-99% -$157K
FMC icon
493
FMC
FMC
$1.42B
$1.18K ﹤0.01%
11
-5,011
-100% -$612K
NEWR
494
DELISTED
New Relic, Inc.
NEWR
$1.15K ﹤0.01%
23
-2,206
-99% -$122K
SI
495
DELISTED
Silvergate Capital Corporation
SI
$1.12K ﹤0.01%
21
-1,304
-98% -$122K
CTAS icon
496
Cintas
CTAS
$82.4B
$1.12K ﹤0.01%
12
AVTR icon
497
Avantor
AVTR
$7.81B
$1.12K ﹤0.01%
36
KSA icon
498
iShares MSCI Saudi Arabia ETF
KSA
$647M
$1.12K ﹤0.01%
27
APTV icon
499
Aptiv
APTV
$12B
$1.07K ﹤0.01%
12
-1,104
-99% -$113K
MPC icon
500
Marathon Petroleum
MPC
$90.3B
$1.07K ﹤0.01%
13
-67
-84% -$6.26K

Similar funds

Exane Derivatives's Q2 2022 Portfolio in Review

As of Q2 2022, Exane Derivatives held 1,070 positions worth $174M, down 51% from $355M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Exane Derivatives withdrew a net $142M in Q2 2022, closing 309 positions and reducing 355 holdings. Its most notable exit was Amazon, an estimated $5.98M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Exane Derivatives opened a new position in iShares Core US Aggregate Bond ETF worth $4.5M.

  • Exane Derivatives's largest Q2 2022 buy was iShares Core US Aggregate Bond ETF: 44,298 shares worth $4.5M.
  • Exane Derivatives added most to Dow Inc in Q2 2022, an estimated $1.28M increase.
  • Exane Derivatives's biggest Q2 2022 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $4.74M.
  • Exane Derivatives fully exited Amazon in Q2 2022, selling an estimated $5.98M.
  • Exane Derivatives's ten largest holdings make up 28% of its $174M portfolio in Q2 2022.
  • Exane Derivatives opened 55 new positions and closed 309 in Q2 2022.
  • Exane Derivatives's portfolio value fell 51% quarter-over-quarter to $174M.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.